Advances in radioligand theranostics in oncology

Thumbnail Image

Files

Lawal_Advances_2024.pdf (708.17 KB)

Date

2024-05

Authors

Lawal, Ismaheel Opeyemi
Abubakar, Sofiullah O.
Ndlovu, Honest
Mokoala, Kgomotso M.G.
More, Stuart
Sathekge, Mike Machaba

Journal Title

Journal ISSN

Volume Title

Publisher

Springer

Abstract

Please read abstract in the article.

Description

Keywords

Lutetium-177 DOTATATE (177Lu-DOTATATE), Lutetium-177 prostate-specific membrane antigen (177Lu-PSMA), Fibroblast activation protein (FAP), Chemokine receptor 4 (CXCR4), Radioligand, Theranostics, Oncology, SDG-03: Good health and well-being

Sustainable Development Goals

SDG-03:Good heatlh and well-being

Citation

Lawal, I.O., Abubakar, S.O., Ndlovu, H. et al. Advances in Radioligand Theranostics in Oncology. Molecular Diagnosis & Therapy 28, 265–289 (2024). https://doi.org/10.1007/s40291-024-00702-4.

URI

http://hdl.handle.net/2263/96534

Collections

Research Articles (Nuclear Medicine)
Research Articles (University of Pretoria)
Full item page